Authors
Loading...
Laboratory study demonstrates selective nanomolar affinity of a monoclonal antibody for cadmium and mercury chelates, suggesting potential for targeted toxic metal sensing and remediation.
Blake et al. (1996) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: